about
The perceptions of pharmacists in Victoria, Australia on pharmacogenetics and its implications.Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.Assessment of the pharmacogenomics educational needs of pharmacists.Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatmentEvidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs.Development and evaluation of a pharmacogenomics educational program for pharmacistsConsideration of patient preferences and challenges in storage and access of pharmacogenetic test resultsPharmacogenetics of drug-induced liver injury.The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?Barriers to integrating personalized medicine into clinical practice: a best-worst scaling choice experiment.Towards a more robust approach to selecting and prosecuting promising targets and compounds.Clinical implementation of pharmacogenetics: a nonrepresentative explorative survey to participants of WorldPharma 2010.Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.Barriers for integrating personalized medicine into clinical practice: a qualitative analysis.Massively Parallel SequencingAre health technology assessments of pharmacogenetic tests feasible? A case study ofCYP2D6testing in the treatment of breast cancer with tamoxifenGenetics, genomics and society: the responsibilities of scientists for science communication and education
P2860
Q30226502-7DA2B796-E87A-464F-B57F-9785DDDD5A37Q34131354-076A279A-5FB7-4287-A105-DD26A4202554Q35030197-1236748C-5893-4E81-8E29-3C89C5DCB79BQ35059965-A215E118-447F-4FCD-845A-24C628874A61Q35762508-0EC985CC-8424-4FC6-9EC8-4A38947A4D4CQ36626572-43A1B262-CE28-4ACC-A39B-EE7DB4E3520DQ37065132-0C094FEC-A6CF-47D9-901B-4A4C13DA2E1CQ37770487-9A202D2D-8A08-4CE3-8A3E-405FB8A075A2Q39150032-C2573618-0292-4C0E-9B5C-C5CCB50C9B9EQ39664940-8D48268F-4EBF-49F2-AA23-55295F149827Q39915228-78CE1274-D333-4EBE-872C-B7456C97B034Q43433258-2652C2BF-95C4-474B-AB8E-32F894799ABDQ43879115-400D55EB-A3D1-4AB5-8F79-BCC299101A83Q53105237-D30E4B49-1BD8-449F-A550-64729A687CEEQ57386650-87180F14-069B-4E96-838D-F5D6BC6C4C81Q57697028-E6A572EA-3BA9-4C7D-9D70-051985ED05A3Q59175009-3E176910-D58B-495A-AAC5-A190ACDF0725
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Pharmacogenetics: from discovery to patient care.
@ast
Pharmacogenetics: from discovery to patient care.
@en
Pharmacogenetics: from discovery to patient care.
@nl
type
label
Pharmacogenetics: from discovery to patient care.
@ast
Pharmacogenetics: from discovery to patient care.
@en
Pharmacogenetics: from discovery to patient care.
@nl
prefLabel
Pharmacogenetics: from discovery to patient care.
@ast
Pharmacogenetics: from discovery to patient care.
@en
Pharmacogenetics: from discovery to patient care.
@nl
P2093
P356
P1476
Pharmacogenetics: from discovery to patient care.
@en
P2093
Jaekyu Shin
Steven R Kayser
Taimour Y Langaee
P304
P356
10.2146/AJHP080170
P577
2009-04-01T00:00:00Z